Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-20

Clinical Trial Update: Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 trial evaluating a novel ibuprofen formulation for episodic tension-type headache; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (novel formulation) (ibuprofen)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2012-08-20